CANCER THERAPY USING A COMBINATION OF CDK7 INHIBITOR WITH AN ANTI-MICROTUBULE AGENT

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20240016811A1
SERIAL NO

18032919

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides a combination of a substituted heterocyclyl derivative of formula (I) or a pharmaceutically acceptable salt thereof which is a CDK7 inhibitor along with an anti-microtubule agent or prodrug thereof, and a method of treating or preventing cancer in a subject, comprising administering to the subject a compound of formula (I) conjointly with the anti-microtubule agent.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
AURIGENE ONCOLOGY LIMITED39/40 (P) KIADB INDUSTRIAL AREA ELECTRONICS CITY PHASE II BANGALORE KARNATAKA BANGALORE 560100 560100

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Kumar, Akhil Karnataka, IN 4 5
Narayanan, Kishore Karnataka, IN 1 0
Poddutoori, Ramulu Karnataka, IN 26 221

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation